Vol 6, No 36

Mitochondrial mass and DNA repair in breast cancer stem cells

Inflammasome effects in GvHD

LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation

An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8⁺ T-cell responses

PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response

The cAMP response element modulator (CREM) regulates T_H2 mediated inflammation

Chromosomal instability triggers cell death via local signalling through the innate immune receptor Toll

Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice

Hepatic TLR4 signaling is activated by LPS from digestive tract during SARA, and epigenetic mechanisms contribute to enforced TLR4 expression

Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?

miRNA interventions serve as ‘magic bullets’ in the reversal of glioblastoma hallmarks

Detection of cancer through exhaled breath: a systematic review

Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer

Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival

MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab

microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu)

A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?

Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis

A microfluidic approach towards hybridoma generation for cancer immunotherapy

Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors

In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer

Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia

Deletion of cyclooxygenase-2 inhibits K-ras–induced lung carcinogenesis

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12

MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells

Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer

Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes

CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer

Tunicamycin enhances the antitumor activity of trastuzumab on breast cancer in vitro and in vivo

Potential role of aquaporin 3 in gastric intestinal metaplasia

Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells

The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling

Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma

Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells

Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells

Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line

Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models

RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration

IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration

Simple and rapid determination of homozygous transgenic mice via in vivo fluorescence imaging

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype

Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma

Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas

Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications

Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies

miRNAs in multiple myeloma – a survival relevant complex regulator of gene expression

Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis

Bladder cancer cells re-educate TAMs through lactate shuttling in the microfluidic cancer microenvironment

REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer

miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma

NOX5-L can stimulate proliferation and apoptosis depending on its levels and cellular context, determining cancer cell susceptibility to cisplatin

Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics

NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro

A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo

Evaluation of pentacyclic triterpenes found in Perilla frutescens for inhibition of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate

Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis

Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline

Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

Efficacy and safety of capecitabine-based first-line chemotherapy in advanced or metastatic breast cancer: a meta-analysis of randomised controlled trials

Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy